These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 7867758

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat.
    Mijnster MJ, Schotte A, Docter GJ, Voorn P.
    Synapse; 1998 Apr; 28(4):302-12. PubMed ID: 9517839
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period.
    Joyce JN.
    Synapse; 2001 May; 40(2):137-44. PubMed ID: 11252025
    [Abstract] [Full Text] [Related]

  • 7. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
    Konieczny J, Wardas J, Kuter K, Pilc A, Ossowska K.
    Neuroscience; 2007 Mar 16; 145(2):611-20. PubMed ID: 17224239
    [Abstract] [Full Text] [Related]

  • 8. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E, Krysiak R, Wieronska JM, Smialowska M, Herman ZS.
    Neuropeptides; 2005 Oct 16; 39(5):515-23. PubMed ID: 16154634
    [Abstract] [Full Text] [Related]

  • 9. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.
    Cenci MA, Lee CS, Björklund A.
    Eur J Neurosci; 1998 Aug 16; 10(8):2694-706. PubMed ID: 9767399
    [Abstract] [Full Text] [Related]

  • 10. Olfactory bulbectomy increases prepro-enkephalin mRNA levels in the ventral striatum in rats.
    Holmes PV.
    Neuropeptides; 1999 Jun 16; 33(3):206-11. PubMed ID: 10657493
    [Abstract] [Full Text] [Related]

  • 11. Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias.
    Egan MF, Hurd Y, Hyde TM, Weinberger DR, Wyatt RJ, Kleinman JE.
    Synapse; 1994 Nov 16; 18(3):178-89. PubMed ID: 7531873
    [Abstract] [Full Text] [Related]

  • 12. Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats.
    Le Foll B, Diaz J, Sokoloff P.
    Synapse; 2003 Mar 16; 47(3):176-83. PubMed ID: 12494400
    [Abstract] [Full Text] [Related]

  • 13. Heterogeneous distribution of dopamine D2 receptor mRNA in the rat striatum: a quantitative analysis with in situ hybridization histochemistry.
    Szele FG, Artymyshyn R, Molinoff PB, Chesselet MF.
    Anat Rec; 1991 Dec 16; 231(4):548-58. PubMed ID: 1838906
    [Abstract] [Full Text] [Related]

  • 14. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
    Yu J, Coirini H, Källström L, Wiesel FA, Johnson AE.
    Synapse; 1998 Sep 16; 30(1):38-48. PubMed ID: 9704879
    [Abstract] [Full Text] [Related]

  • 15. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M, Lévesque D, Di Paolo T.
    Mol Pharmacol; 1992 Sep 16; 42(3):480-8. PubMed ID: 1357544
    [Abstract] [Full Text] [Related]

  • 16. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
    Morissette M, Goulet M, Calon F, Falardeau P, Blanchet PJ, Bédard PJ, Di Paolo T.
    Mol Pharmacol; 1996 Nov 16; 50(5):1073-9. PubMed ID: 8913337
    [Abstract] [Full Text] [Related]

  • 17. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May 16; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 18. Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.
    Humpel C, Knaus GA, Auer B, Knaus HG, Haring C, Theodorsson E, Saria A.
    Synapse; 1990 May 16; 6(1):1-9. PubMed ID: 1697986
    [Abstract] [Full Text] [Related]

  • 19. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D.
    Eur J Pharmacol; 2009 Oct 12; 620(1-3):27-35. PubMed ID: 19695244
    [Abstract] [Full Text] [Related]

  • 20. Regulation of striatal dopamine receptors by estrogen.
    Lammers CH, D'Souza U, Qin ZH, Lee SH, Yajima S, Mouradian MM.
    Synapse; 1999 Dec 12; 34(3):222-7. PubMed ID: 10523759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.